Publications Database

Quintana H. et al. (1995)

Use of methylphenidate in the treatment of children with autistic disorder.

Journal of Autism and Developmental Disorders

25(3), pp. 283-294

Read Abstract (New Window)

Realmuto G. , August G. , Garfinkel B. (1989)

Clinical effect of buspirone in autistic children.

Journal of Clinical Psychopharmacology

9(2), pp. 122-125

Read Abstract (New Window)

Reichow B. , Volkmar F. R. , Bloch M. H. (2013)

Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

43(10), pp. 2435-2441.

Read Abstract (New Window) Read Full (New Window)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2005)

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Archives of General Psychiatry

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network 62(11), pp. 1266-1274

Read Abstract (New Window) Read Full (New Window)

Rosenberg R. E. et al. (2010)

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

Journal of Autism and Developmental Disorders

40(3), pp. 342-351.

Read Abstract (New Window)

Roy M. et al. (2009)

Effective methylphenidate treatment of an adult Aspergers syndrome and a comorbid ADHD: A clinical investigation with fMRI.

Journal of Attention Disorders

12(4), pp. 381-385

Read Abstract (New Window)

Royal College of Psychiatrists (2017)

Attention-deficit hyperactivity disorder and hyperkinetic disorder: information for parents, carers and anyone working with young people

London: Royal College of Psychiatrists

Read Full (New Window)

Santosh P. J. et al. (2006)

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Child: Care, Health and Development

32(5), pp. 575-583

Read Abstract (New Window)

Santosh P. J. , Baird G. (2001)

Pharmacotherapy of target symptoms in autistic spectrum disorders.

Indian Pediatrics

68(5), pp. 427-431

Read Abstract (New Window)

Scahill L. et al. (2017)

Using a patient-centered outcome measure to test methylphenidate versus placebo in children with autism spectrum disorder.

Journal of Child and Adolescent Psychopharmacology

March, 27(2), pp. 125-131.

Read Abstract (New Window) Read Full (New Window)

Simonoff E. et al. (2013)

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

Journal of Child Psychology and Psychiatry

54(5), pp. 527-535.

Read Abstract (New Window)

Smile S. , Anagnostou E. (0000)

New models for considering the role of medication in the treatment and elucidation of the etiology of autism.

Current Psychiatry Reports

Read Abstract (New Window)

Stepanova E. et al. (2017)

Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.

Dialogues in Clinical Neuroscience

19 pp. 395-402.

Read Abstract (New Window)

Stigler K. A. et al. (2004)

A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 49-56

Read Abstract (New Window)

Strayhorn J. M. et al. (1998)

Randomized trial of methylphenidate for an autistic child.

Journal of the American Academy of Child and Adolescent Psychiatry

27(2), pp. 244-247

Read Abstract (New Window)

Sturman N. , Deckx L. , van Driel M. L. (2017)

Methylphenidate for children and adolescents with autism spectrum disorder.

Cochrane Database of Systematic Reviews

(11),

Read Abstract (New Window) Read Full (New Window)

Taylor L. J. (2016)

Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review.

Research in Autism Spectrum Disorders

25 pp. 58-75.

Read Abstract (New Window)

US Food and Drug Administration (2007)

Methylphenidate.

Bethesda, MD: US National Library of Medicine.

Read Full (New Window)

West L. , Waldrop J. , Brunssen S. (2009)

Pharmacologic treatment for the core deficits and associated symptoms of autism in children.

Journal of Pediatric Health Care

23(2), pp. 75-89

Read Abstract (New Window)

Wink L. K. , Erickson C. A. , McDougle C. J. (2010)

Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders.

Current Treatment Options in Neurology

12(6), pp. 529-538.

Read Abstract (New Window)